Cetin, B. Et Al. 2022. CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer. FUTURE ONCOLOGY , vol.18, no.9 , 1143-1157.

Cetin, B., Wabl, C. A., & Gumusay, Ö., (2022). CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer. FUTURE ONCOLOGY , vol.18, no.9, 1143-1157.

Cetin, Bulent, Chiara A. Wabl, And ÖZGE GÜMÜŞAY. "CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer," FUTURE ONCOLOGY , vol.18, no.9, 1143-1157, 2022

Cetin, Bulent Et Al. "CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer." FUTURE ONCOLOGY , vol.18, no.9, pp.1143-1157, 2022

Cetin, B. Wabl, C. A. And Gumusay, Ö. (2022) . "CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer." FUTURE ONCOLOGY , vol.18, no.9, pp.1143-1157.

@article{article, author={Bulent Cetin Et Al. }, title={CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer}, journal={FUTURE ONCOLOGY}, year=2022, pages={1143-1157} }